no pathway map

News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Western blot analysis of extracts from NIH/3T3 cells, using Phospho-p44/42 MAP Kinase (Thr202/Tyr204) Antibody #9101 or control p44/42 MAP Kinase Antibody #9102. NIH/3T3 cells were pretreated with U0126 for 2 hours then treated with 20% serum for 30 minutes.

Learn more about how we got this image
Image

Product Usage Information

U0126 is supplied as a lyophilized white powder. For 10 mM stock, resuspend 5 mg of the inhibitor in 1.31 ml DMSO. Methanol can be substituted for DMSO. Aliquot and freeze at -20ºC or below to avoid multiple freeze/thaw cycles which can degrade the inhibitor. For experiments with cultured cells, we recommend pretreating the cells with U0126 at 10 µM for 30 minutes to two hours prior to stimulation. (It may be necessary to use higher concentrations.) This product is for in vitro research use only and is not intended for use in humans or animals.

U0126 has been shown to be a highly selective inhibitor of MEK 1 and MEK 2. When compared with PD98059 #9900, U0126 shows a significantly higher affinity for MEK1. U0126 and PD98059 bind to this enzyme in a mutually exclusive fashion suggesting that they share a common binding site (5). U0126 is able to inhibit both MEK1 and MEK2 while PD98059 inhibits MEK1 more potently than MEK2.


Storage: Store at -20°C.

Product Description

Molecular Weight:

380.50 g/mol


Purity:

>99%


Molecular Formula:

C18H16N6S2


MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.


1.  Crews, C.M. et al. (1992) Science 258, 478-480.

2.  Alessi, D.R. et al. (1994) EMBO J. 13, 1610-1619.

3.  Rosen, L.B. et al. (1994) Neuron 12, 1207-1221.

4.  Cowley, S. et al. (1994) Cell 77, 841-852.

5.  Favata, M.F. et al. (1998) J Biol Chem 273, 18623-32.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.